Some perspective: not every MAB has the truly sublime

New Post Public Reply Private Reply Replies (0) Message Board
JLang
816
Some perspective: not every MAB has the truly sublime safety profile of LLMab.. if the FDA sees safety flags or low efficacy, they aren't shy about saying it:

Quote:
https://www.fiercebiotech.com/biotech/pfizer-...afety-risk

Pfizer and Eli Lilly’s long journey to a potential FDA approval for tanezumab still looked rocky today after review documents from the regulator cast doubt over its safety.

Ahead of an outside expert committee meeting midweek, the FDA as always released its thoughts and discussion points on the drug, and, while finding strong evidence that it helps osteoarthritis patients, it says there are critical safety risks that may cost the partners a straight shot on goal.
[Briefing Doc: https://www.fda.gov/media/146867/download ]

The main safety worry is so-called rapidly progressing osteoarthritis, or RPOA, which the companies are aware of. They are looking to run the drug under the FDA’s Risk Evaluation and Mitigation Strategy (REMS) to try to keep a close eye on this issue.

The FDA, however, is not convinced. “The review team has concerns that the Applicant’s proposed REMS is not sufficient to mitigate the risk of RPOA and would not ensure that the benefits of tanezumab outweigh the risks of RPOA,” the U.S. regulator said in the review documents.

“In spite of the risk mitigation strategies in clinical studies, the risk of developing RPOA remained concerning, as a large number of patients with RPOA required total joint replacements (TJR); 15% of patients progressed to total joint replacement (TJR) following RPOA1, and 60% of patients with RPOA2 progressed to TJR.”

It added that stopping drug after patients develop RPOA also “does not appear to be effective in preventing further damage to the joints,” while needing precision and consistency of the medical imaging and interpretation it says “do not appear feasible in practice.”

Another black mark was that the drug can cause abnormal peripheral sensation characterized as (predominantly) mild, self-limited mononeuropathy (singular nerve damage), with the most common coming out as carpal tunnel syndrome.

While saying that overall, the drug appears to work, it saw its efficacy as “modest” and not showing up better than much older and cheaper non-steroidal anti-inflammatory drugs (NSAIDs).

RELATED: Lilly, Pfizer's phase 3 pain data show mixed efficacy, clear safety issues

This is probably not altogether surprising: Two years back, Pfizer and Lilly published phase 3 data that painted a mixed picture of the safety and efficacy of the pair’s painkiller. Neither dose of the nerve growth factor inhibitor hit all the co-primary efficacy goals, and both fared worse than placebo on the safety assessments.

At the time, Wolfe Research analyst Tim Anderson did not mince his words: “To us, the product is likely dead, if not from a regulatory standpoint (i.e., is it even approvable?) then from a commercial one (i.e., will it ever sell?).”

The FDA documents conclude that: “No final decision has been made for this application, however, and the entire review team greatly looks forward to the insights that you can provide at the advisory committee meeting.” That happens Wednesday, but it might not be the easiest of days for the pharmas and comes after a 15-year journey for this tortured drug.


Waiting for Closet and Co. to go demand they sack management at LLY and PFE.. Have a mic set up to catch the thunderous laughter when they get the demands.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 113

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 34

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 86

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 16

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 427

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 372

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 42

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 103

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 55

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading

Top 5 Most Recently Viewed Articles

E-commerce Brands Make Striking Debut at Fashion Week

Updated Category News Views 96

E-commerce Brands Shine at Fashion Week In an exciting turn for the fashion world, online powerhouses Coofandy and Ekouaer have made a memorable entrance at New York Fashion Week (NYFW). They brought along the star power of supermodels Helena Christensen and Sean O'Pry to help spotlight their brands. Coofandy, known for its stylish menswear, and Ekouaer, which specializes...

Continue Reading
Tallinna Vesi Plans To Adjust Water Service Prices in 2025

Updated Category News Views 182

Tallinna Vesi Plans Adjustment of Water Supply Prices for 2025 Tallinna Vesi has submitted an application to change the prices of its water supply services, pending approval from the Competition Authority. The changes, projected to take effect in 2025, are rooted in legal requirements to standardize pricing for both private and business customers. This initiative aims to...

Continue Reading
Investor Insights: Bullish Moves in PDD Holdings Options

Updated Category News Views 131

Unusual Options Activity in PDD Holdings In recent trading sessions, investors with substantial capital have taken a bullish stance toward PDD Holdings (NASDAQ: PDD). This behavior is drawing significant attention in the financial landscape, suggesting that noteworthy changes may be on the horizon. Our latest findings highlight this trend and delve into the implications...

Continue Reading
AI and Software Spending Surge: Insights for Businesses in 2025

Updated Category News Views 426

AI and Software Spending Trends Shaping 2025 As companies continue to adapt to evolving market demands, one thing has become abundantly clear: software spending is on the rise. The landscape of corporate technology acquisitions has changed dramatically, with a reported increase of 10% in software spending in recent times. This growth mirrors the increasing integration of...

Continue Reading
Unleashing Summer Fun: Kinder Chocolate and Paul George Unite

Updated Category News Views 227

Refreshing Summer with Kinder Chocolate's Brand Campaign In a delightful move that captures the essence of summer joy, Kinder Chocolate is launching a vibrant campaign called Pass The Fun. With an exciting collaboration featuring NBA All-Star Paul George, the campaign promises to spark joyful moments for families and kids through basketball this summer. This initiative...

Continue Reading